Levi Garraway, Roche’s chief medical officer and head of global product development, said: “The INAVO120 overall survival ...
If 2024 saw an unparalleled acceleration in the wider public’s awareness of AI, then 2025 will be the year when its practical application becomes mainstream.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback